Research Paper Volume 15, Issue 11 pp 4757—4773
Knocking down NSUN5 inhibits the development of clear cell renal cell carcinoma by inhibiting the p53 pathway
Figure 5. Correlation between the risk score and the TME score, TIDE score, and immune check point. (A) TIDE scores with the low- and high-risk groups. (B) Immune, stromal and ESTIMATE scores with the low- and high-risk groups. (C) Tumor purity with the low- and high-risk groups. (D) Heat map of the correlation between NSUN5 and immune check points. (E) Drug sensitivity analysis (*P < 0.05, **P < 0.01).